Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

被引：46

作者：

Jagu, Subhashini ^{[1
]}

Kwak, Kihyuck ^{[1
]}

Garcea, Robert L. ^{[2
]}

Roden, Richard B. S. ^{[1
,3
,4
]}

机构：

[1] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA

[2] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA

[3] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21231 USA

[4] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21231 USA

来源：

VACCINE | 2010年 / 28卷 / 28期

基金：

美国国家卫生研究院;

关键词：

Human papillomavirus; L1; VLP; Capsomeres; Capsomers; L2; Multimeric; VIRUS-LIKE PARTICLES; HUMAN-PAPILLOMAVIRUS TYPE-16; IMMUNOSTIMULATORY PHOSPHOROTHIOATE OLIGONUCLEOTIDE; CAPSID PROTEIN; SUSTAINED EFFICACY; YOUNG-WOMEN; IMMUNIZATION; IMMUNOGENICITY; NEUTRALIZATION; VACCINES;

D O I：

10.1016/j.vaccine.2010.04.039

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunization with L1 as pentavalent capsomeres or virus-like particles (VLPs) generates high and long-lived titers of neutralizing antibodies and protection primarily against the human papillomavirus (HPV) type from which the vaccine was derived. Conversely, vaccination with 12 minor capsid protein derived from multiple HPV types induces lower titer, but more broadly neutralizing and protective antibody responses. We combined the advantages of each protective antigen by immunization with titrated doses of multi-type L2 with either L1 capsomeres or VLP. We observed no significant interference between the L1 and L2 antibody response upon co-administration of L1 vaccines with multi-type L2 vaccines. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：4478 / 4486

页数：9

共 46 条

[1] Crystal structures of four types of human papillomavirus L1 capsid - Understanding the specificity of neutralizing monoclonal antibodies [J].

Bishop, Brooke ;

Dasgupta, Jhimli ;

Klein, Michael ;

Garcea, Robert L. ;

Christensen, Neil D. ;

Zhao, Rui ;

Chen, Xiaojiang S. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (43) :31803-31811

[2] IMMUNIZATION WITH VIRUS-LIKE PARTICLES FROM COTTONTAIL RABBIT PAPILLOMAVIRUS (CRPV) CAN PROTECT AGAINST EXPERIMENTAL CRPV INFECTION [J].

BREITBURD, F ;

KIRNBAUER, R ;

HUBBERT, NL ;

NONNENMACHER, B ;

TRINDINHDESMARQUET, C ;

ORTH, G ;

SCHILLER, JT ;

LOWY, DR .

JOURNAL OF VIROLOGY, 1995, 69 (06) :3959-3963

[3] The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16-26 Years [J].

Brown, Darron R. ;

Kjaer, Susanne K. ;

Sigurdsson, Kristjan ;

Iversen, Ole-Erik ;

Hernandez-Avila, Mauricio ;

Wheeler, Cosette M. ;

Perez, Gonzalo ;

Koutsky, Laura A. ;

Tay, Eng Hseon ;

Garcia, Patricia ;

Ault, Kevin A. ;

Garland, Suzanne M. ;

Leodolter, Sepp ;

Olsson, Sven-Eric ;

Tang, Grace W. K. ;

Ferris, Daron G. ;

Paavonen, Jorma ;

Steben, Marc ;

Bosch, F. Xavier ;

Dillner, Joakim ;

Joura, Elmar A. ;

Kurman, Robert J. ;

Majewski, Slawomir ;

Munoz, Nubia ;

Myers, Evan R. ;

Villa, Luisa L. ;

Taddeo, Frank J. ;

Roberts, Christine ;

Tadesse, Amha ;

Bryan, Janine ;

Lupinacci, Lisa C. ;

Giacoletti, Katherine E. D. ;

Sings, Heather L. ;

James, Margaret ;

Hesley, Teresa M. ;

Barra, Eliav .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07) :926-935

[4] A peptide encoding a B-cell epitope from the N-terminus of the capsid protein L2 of bovine papillomavirus-4 prevents disease [J].

Campo, MS ;

ONeil, BW ;

Grindlay, GJ ;

Curtis, F ;

Knowles, G ;

Chandrachud, L .

VIROLOGY, 1997, 234 (02) :261-266

[5] Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 [J].

Chen, XJS ;

Garcea, RL ;

Goldberg, I ;

Casini, G ;

Harrison, SC .

MOLECULAR CELL, 2000, 5 (03) :557-567

[6] Papillomavirus capsid protein expression in Escherichia coli:: Purification and assembly of HPV11 and HPV16 L1 [J].

Chen, XJS ;

Casini, G ;

Harrison, SC ;

Garcea, RL .

JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (01) :173-182

[7] THE OPEN READING FRAME L2 OF COTTONTAIL RABBIT PAPILLOMAVIRUS CONTAINS ANTIBODY-INDUCING NEUTRALIZING EPITOPES [J].

CHRISTENSEN, ND ;

KREIDER, JW ;

KAN, NC ;

DIANGELO, SL .

VIROLOGY, 1991, 181 (02) :572-579

[8] Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus [J].

Christensen, ND ;

Reed, CA ;

Cladel, NM ;

Han, R ;

Kreider, JW .

JOURNAL OF VIROLOGY, 1996, 70 (02) :960-965

[9] Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies [J].

Day, Patricia M. ;

Garnbhira, Ratish ;

Roden, Richard B. S. ;

Lowy, Douglas R. ;

Schiller, John T. .

JOURNAL OF VIROLOGY, 2008, 82 (09) :4638-4646

[10] Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years [J].

Einstein, Mark H. ;

Baron, Mira ;

Levin, Myron J. ;

Chatterjee, Archana ;

Edwards, Robert P. ;

Zepp, Fred ;

Carletti, Isabelle ;

Dessy, Francis J. ;

Trofa, Andrew F. ;

Schuind, Anne ;

Dubin, Gary .

HUMAN VACCINES, 2009, 5 (10) :705-719

← 1 2 3 4 5 →